Chase Pharmaceuticals

Chase Pharmaceuticals focuses on the development of medications for the treatment of neurodegenerative disorders. Read more

Douglas S. Ingram's photo - CEO of Chase Pharmaceuticals

CEO

Douglas S. Ingram

CEO Approval Rating

68/100

CHASE PHARMACEUTICALS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Alector is one of Chase Pharmaceuticals's top rivals. Alector is a Public company that was founded in 2013 in South San Francisco, California. Alector competes in the Biotechnology industry. Compared to Chase Pharmaceuticals, Alector has 47 more employees.

Gismo Therapeutics is seen as one of Chase Pharmaceuticals's biggest rivals. Gismo Therapeutics was founded in 2011 in Lexington, Kentucky. Like Chase Pharmaceuticals, Gismo Therapeutics also works within the Health Care Services field. Gismo Therapeutics generates $4.6M more revenue than Chase Pharmaceuticals.

Pharnext is one of Chase Pharmaceuticals's top competitors. Pharnext was founded in 2007, and its headquarters is in Paris, Île-de-France. Like Chase Pharmaceuticals, Pharnext also operates in the Health Care Services sector. Pharnext has 77 fewer employees than Chase Pharmaceuticals.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 124 a good estimate for Chase Pharmaceuticals's Employee count?

Chase Pharmaceuticals Acquisitions

No recent acquisitions found related to Chase Pharmaceuticals

Chase Pharmaceuticals Funding History

Since Chase Pharmaceuticals was founded in 2007, it has participated in 4 rounds of funding. In total Chase Pharmaceuticals has raised $22.8M. Chase Pharmaceuticals' last funding round was on Mar 2016 for a total of $12.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Mar 2016
$12M
Equity
Aug 2015
$3.5M
-
Series B
May 2014
$6.1M
Equity
Nov 2010
$1.2M
-

Since Chase Pharmaceuticals was founded in 2007, it has participated in 4 rounds of funding. In total Chase Pharmaceuticals has raised $22.8M. Chase Pharmaceuticals' last funding round was on Mar 2016 for a total of $12.0M

Chase Pharmaceuticals Investments

No recent investments found related to Chase Pharmaceuticals

Chase Pharmaceuticals News

June 20, 2016BioPortfolio

Chase adds former Allergan execs to leadership team

Scott Giacobello and Gary Charbonneau join... See more »
June 12, 2016Orange County Business Journal

New OC Company Developing Cannabis-Based Drug

Douglas Ingram's drug development work encompasses more than just Alzheimer's disease, which his Irvi... See more »
June 6, 2016BioPortfolio

Chase Pharmaceuticals Continues to Build Its Senior Leadership Team with Appointment of Two Healthcare Industry Veterans

Monday June 6th 2016 at 902pm UTC IRVINE Calif.&8211;BUSINESS WIRE&8211; Chase Pharmaceuticals Corpor... See more »
June 5, 20164-traders

Chase Pharmaceuticals Continues to Build Its Senior Leadership Team with Appointment of Two Healthcare Industry Veterans

(4-traders.com) Chase Pharmaceuticals Corporation (Chase), a clinical-stage biopharmaceutical company... See more »
June 5, 2016Orange County Business Journal

Allergan Vet Brings Pharma Startup to OC

Drug development startup Chase Pharmaceuticals Corp. is now being led from Irvine with a familiar fac... See more »

Chase Pharmaceuticals Blogs

December 10, 2015Chase Pharmaceuticals Blog

"High Dose Donepezil Treatment of Alzheimer's Disease" Poster Presented on December 9 by Thomas N. Chase, MD

Preliminary Results from CPC-201 and CPC-212 TrialsBackground: Cholinesterase inhibitors (ChEIs) rema... See more »
May 14, 2014Chase Pharmaceuticals Blog

Chase Pharmaceuticals Raises $21 million in Series B Financing

Chase Pharmaceuticals Corporation today announced a $21 million Series B financing via a syndicate le... See more »

Chase Pharmaceuticals Press Releases

May 12, 2014BUSINESS WIRE

INSERTING and REPLACING Chase Pharmaceuticals Raises $21 Million in Series B Financing

WASHINGTON--(BUSINESS WIRE)--Chase Pharmaceuticals announced a $21 million Series B financing via a s... See more »

Social Media

Chase Pharmaceuticals Headquarters

1825 K St NW Suite 510

Washington, District of Columbia20006

202-792-4621

Driving Directions »

Trending Companies

Chase Pharmaceuticals Summary

ABOUT

Overview

Chase Pharmaceuticals focuses on the development of medications for the treatment of neurodegenerative disorders. Chase Pharmaceuticals was founded in 2007. Chase Pharmaceuticals' headquarters is located in Washington, District of Columbia, USA 20006....

CEO

Chase Pharmaceuticals's CEO, Douglas S. Ingram, currently has an approval rating of 68%. Chase Pharmaceuticals's primary competitors are Alector, Gismo Therapeutics & Pharnext.

Frequently Asked Questions about Chase Pharmaceuticals

  1. When was Chase Pharmaceuticals founded?

    Chase Pharmaceuticals was founded in 2007
  2. Who is Chase Pharmaceuticals's CEO?

    Chase Pharmaceuticals's CEO is Douglas S. Ingram
  3. How much revenue does Chase Pharmaceuticals generate?

    Chase Pharmaceuticals generates $ < 1M in revenue
  4. How much funding does Chase Pharmaceuticals have?

    Chase Pharmaceuticals has historically raised $22.8M in funding
  1. Where is Chase Pharmaceuticals's headquarters?

    Chase Pharmaceuticals's headquarters is in Washington District of Columbia, USA
  2. How many employees does Chase Pharmaceuticals have?

    Chase Pharmaceuticals has 124 employees
  3. What sector does Chase Pharmaceuticals operate in?

    Chase Pharmaceuticals is in Health Care Services
  4. Who are Chase Pharmaceuticals's competitors?

    Chase Pharmaceuticals's top competitors are Alector, Gismo Therapeutics, Pharnext